Literature DB >> 15036939

Lessons learned from the development of imatinib.

Nicholas B Lydon1, Brian J Druker.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15036939     DOI: 10.1016/j.leukres.2003.10.002

Source DB:  PubMed          Journal:  Leuk Res        ISSN: 0145-2126            Impact factor:   3.156


× No keyword cloud information.
  12 in total

Review 1.  Extracellular matrix molecules: potential targets in pharmacotherapy.

Authors:  Hannu Järveläinen; Annele Sainio; Markku Koulu; Thomas N Wight; Risto Penttinen
Journal:  Pharmacol Rev       Date:  2009-06       Impact factor: 25.468

2.  Sphingomyelin synthase 1 activity is regulated by the BCR-ABL oncogene.

Authors:  Tara Ann Burns; Marimuthu Subathra; Paola Signorelli; Young Choi; Xiaofeng Yang; Yong Wang; Maristella Villani; Kapil Bhalla; Daohong Zhou; Chiara Luberto
Journal:  J Lipid Res       Date:  2012-11-16       Impact factor: 5.922

Review 3.  Contribution of tumoral and host solute carriers to clinical drug response.

Authors:  Jason A Sprowl; Torben S Mikkelsen; Hugh Giovinazzo; Alex Sparreboom
Journal:  Drug Resist Updat       Date:  2012-03-28       Impact factor: 18.500

4.  Philadelphia Chromosome Symposium: commemoration of the 50th anniversary of the discovery of the Ph chromosome.

Authors:  H Sharat Chandra; Nora C Heisterkamp; Alice Hungerford; Jennifer J D Morrissette; Peter C Nowell; Janet D Rowley; Joseph R Testa
Journal:  Cancer Genet       Date:  2011-04

Review 5.  Emerging strategies for EphA2 receptor targeting for cancer therapeutics.

Authors:  Manish Tandon; Sai Vikram Vemula; Suresh K Mittal
Journal:  Expert Opin Ther Targets       Date:  2011-01       Impact factor: 6.902

Review 6.  Extrinsic regulation of hematopoietic stem cells in development, homeostasis and diseases.

Authors:  Yeojin Lee; Matthew Decker; Heather Lee; Lei Ding
Journal:  Wiley Interdiscip Rev Dev Biol       Date:  2017-05-31       Impact factor: 5.814

7.  Study of critical role of c-Met and its inhibitor SU11274 in colorectal carcinoma.

Authors:  Wei Gao; Xue Bing; MingYan Li; Zhanhua Yang; Ying Li; Hua Chen
Journal:  Med Oncol       Date:  2013-03-28       Impact factor: 3.064

Review 8.  Cancer driver mutations in protein kinase genes.

Authors:  Ali Torkamani; Gennady Verkhivker; Nicholas J Schork
Journal:  Cancer Lett       Date:  2008-12-10       Impact factor: 8.679

Review 9.  AMPK in BCR-ABL expressing leukemias. Regulatory effects and therapeutic implications.

Authors:  Eliza Vakana; Leonidas C Platanias
Journal:  Oncotarget       Date:  2011-12

10.  Suppression of programmed cell death 4 (PDCD4) protein expression by BCR-ABL-regulated engagement of the mTOR/p70 S6 kinase pathway.

Authors:  Nathalie Carayol; Efstratios Katsoulidis; Antonella Sassano; Jessica K Altman; Brian J Druker; Leonidas C Platanias
Journal:  J Biol Chem       Date:  2008-01-26       Impact factor: 5.157

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.